On January 31, 2011 we changed our name to Laureate Biopharmaceutical Services, Inc. For all current connections please see the LinkedIn page for Laureate Biopharmaceutical Services, Inc. We are a full-service biopharmaceutical contract development and manufacturing organization. Laureate’s scientists are expert in process development and cGMP production of therapeutic proteins including monoclonal antibodies and Fc-fusion proteins. In addition, the company’s portfolio of services includes aseptic filling, cell line development, analytical and stability testing, and regulatory support. Laureate has served a global client base from its Princeton, New Jersey facility since 1981 and is a portfolio company of Saints Capital, LLC.
Cell Line Optimization, Upstream & Downstream Process Development, Small-Scale Pilot Production, Bioreactor Production from 20 to 2,000L, Purification at Scale, Protein Modification and Conjugation, Formulation and Aseptic Filling